AGFG1 and peripheral neuropathy: Furthermore, aside from the typical AEs of myelosuppression and GI effects, RAB does not have overlapping unique toxicities (eg, cardiotoxicity, peripheral neuropathy, sterile haemorrhagic cystitis) associated with other drugs in the CHOP protocol.1, 3, 4, 5, 9, 10, 22